Shen Y, Li J, Zhao Z, Chen X
Front Cardiovasc Med. 2025; 12:1522544.
PMID: 39898106
PMC: 11782120.
DOI: 10.3389/fcvm.2025.1522544.
Wei X, Cun D, Yang D, Yi Q, Tian D
Turk J Gastroenterol. 2024; 35(12):933-944.
PMID: 39641310
PMC: 11639604.
DOI: 10.5152/tjg.2024.24140.
Qi X, Luo G, Tuersun A, Chen M, Wu G, Zheng L
Heliyon. 2024; 10(19):e38342.
PMID: 39398070
PMC: 11471205.
DOI: 10.1016/j.heliyon.2024.e38342.
Yang J, Gao L, Wang Z, Xu Y, Jin X, Jin Q
Sci Rep. 2024; 14(1):22624.
PMID: 39349960
PMC: 11442952.
DOI: 10.1038/s41598-024-72181-w.
Tesarova T, Fiala O, Hora M, Vaclavikova R
Nat Rev Urol. 2024; 22(3):151-174.
PMID: 39242964
DOI: 10.1038/s41585-024-00926-3.
Implications of mC modifications in ribosomal proteins on oxidative stress, metabolic reprogramming, and immune responses in patients with mid-to-late-stage head and neck squamous cell carcinoma: Insights from nanopore sequencing.
Lin G, Cai H, Hong Y, Yao M, Ye W, Li W
Heliyon. 2024; 10(14):e34529.
PMID: 39149042
PMC: 11324834.
DOI: 10.1016/j.heliyon.2024.e34529.
Nanoliposomes as nonviral vectors in cancer gene therapy.
Yildiz S, Entezari M, Paskeh M, Mirzaei S, Kalbasi A, Zabolian A
MedComm (2020). 2024; 5(7):e583.
PMID: 38919334
PMC: 11199024.
DOI: 10.1002/mco2.583.
Cancer-derived exosomal lncRNA SNHG3 promotes the metastasis of colorectal cancer through hnRNPC-mediating RNA stability of β-catenin.
Huang L, Yang G, Shao Y, Sun J, Yang X, Hong H
Int J Biol Sci. 2024; 20(7):2388-2402.
PMID: 38725844
PMC: 11077369.
DOI: 10.7150/ijbs.88313.
Long noncoding RNA SNHG3 interacts with microRNA-502-3p to mediate ITGA6 expression in liver hepatocellular carcinoma.
Guo J, Zhang J, Xiang Y, Zhou S, Yang Y, Zheng J
Cancer Sci. 2024; 115(7):2286-2300.
PMID: 38680094
PMC: 11247603.
DOI: 10.1111/cas.16190.
SNHG3/WISP2 Axis Promotes Hela Cell Migration and Invasion Activating Wnt/β-Catenin Signaling.
Xu D, Feng H, Ren Z, Li X, Jiang C, Chen Y
Cancer Genomics Proteomics. 2023; 20(6suppl):744-753.
PMID: 38035707
PMC: 10687733.
DOI: 10.21873/cgp.20421.
Knockdown of long non-coding RNA SNHG3 inhibits proliferation, migration and invasion of human thyroid cancer via miR-339-5p/GPR62 axis.
Tang J, Huang X
Heliyon. 2023; 9(9):e19713.
PMID: 37809703
PMC: 10559012.
DOI: 10.1016/j.heliyon.2023.e19713.
lncSNHG3 drives breast cancer progression by epigenetically increasing CSNK2A1 expression level.
Nie Z, Xu M, Zhou L, Pan B, Xu T, He B
Aging (Albany NY). 2023; 15(12):5734-5750.
PMID: 37348024
PMC: 10333090.
DOI: 10.18632/aging.204824.
-associated soft tissue tumors with bone metaplasia: Clinicopathologic and genetic analysis and the identification of novel fusion partners.
Zhang Y, Qiu Y, Zhang X, He X, Chen C, Chen M
Front Oncol. 2023; 12:1065071.
PMID: 36727055
PMC: 9885078.
DOI: 10.3389/fonc.2022.1065071.
Long Non-Coding RNA Expression in Women with Endometriosis: A Pilot Study.
Szaflik T, Romanowicz H, Szyllo K, Smolarz B
Genes (Basel). 2023; 14(1).
PMID: 36672893
PMC: 9859099.
DOI: 10.3390/genes14010152.
A novel prognostic signature for lung adenocarcinoma based on cuproptosis-related lncRNAs: A Review.
Di H, Zhao J, Zhu X, Zhou X, Hu Y, Wang M
Medicine (Baltimore). 2023; 101(49):e31924.
PMID: 36626411
PMC: 9750635.
DOI: 10.1097/MD.0000000000031924.
Silencing the expression of lncRNA may be a novel therapeutic approach in human breast cancer through regulating .
Zhu M, Xiang H, Peng Z, Ma Z, Shen J, Wang T
Ann Transl Med. 2022; 10(21):1173.
PMID: 36467335
PMC: 9708471.
DOI: 10.21037/atm-22-5275.
Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma.
Zhao J, Li G, Zhao G, Wang W, Shen Z, Yang Y
Front Oncol. 2022; 12:986367.
PMID: 36387240
PMC: 9664164.
DOI: 10.3389/fonc.2022.986367.
Integrated analysis of immune- and apoptosis-related lncRNA-miRNA-mRNA regulatory network in children with Henoch Schönlein purpura nephritis.
Huang L, Li Y, Wang P, Xie Y, Liu F, Mao J
Transl Pediatr. 2022; 11(10):1682-1696.
PMID: 36345450
PMC: 9636465.
DOI: 10.21037/tp-22-437.
Identification of senescence-associated long non-coding RNAs to predict prognosis and immune microenvironment in patients with hepatocellular carcinoma.
Gao C, Zhou G, Cheng M, Feng L, Cao P, Zhou G
Front Genet. 2022; 13:956094.
PMID: 36330438
PMC: 9624069.
DOI: 10.3389/fgene.2022.956094.
LncmiRHG-MIR100HG: A new budding star in cancer.
Wu Y, Wang Z, Yu S, Liu D, Sun L
Front Oncol. 2022; 12:997532.
PMID: 36212400
PMC: 9544809.
DOI: 10.3389/fonc.2022.997532.